ProCE Banner Activity

Selecting Initial Treatments and Future Directions in Myelofibrosis

Slideset

Slides featuring expert perspectives on current and emerging therapeutics for patients with myelofibrosis

Released: December 01, 2023

Share

Faculty

Abdulraheem Yacoub

Abdulraheem Yacoub, MD

Professor
The Division of Hematologic Malignancies and Cellular Therapeutics
University of Kansas Medical Center
The University of Kansas Health System
Westwood, Kansas

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from CTI BioPharma Corp., Geron Corporation, GlaxoSmithKline LLC, and Karyopharm Therapeutics Inc.

CTI BioPharma Corp., a Sobi Company

Geron Corporation

GlaxoSmithKline LLC

Karyopharm Therapeutics Inc.